Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
B Isho, KT Abe, M Zuo, AJ Jamal, B Rathod… - Science …, 2020 - science.org
While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the antibody response in saliva and its relationship to systemic …
relatively little is known about the antibody response in saliva and its relationship to systemic …
A proximity-dependent biotinylation map of a human cell
Compartmentalization is a defining characteristic of eukaryotic cells, and partitions distinct
biochemical processes into discrete subcellular locations. Microscopy 1 and biochemical …
biochemical processes into discrete subcellular locations. Microscopy 1 and biochemical …
[PDF][PDF] High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies
…, M Bashkurov, GI Chen, H Bagci, B Rathod… - Molecular cell, 2018 - cell.com
mRNA processing, transport, translation, and ultimately degradation involve a series of
dedicated protein complexes that often assemble into large membraneless structures such as …
dedicated protein complexes that often assemble into large membraneless structures such as …
[HTML][HTML] Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against …
…, G Blacker, M Fazel-Zarandi, B Rathod… - Mucosal …, 2022 - nature.com
Although SARS-CoV-2 infects the upper respiratory tract, we know little about the amount,
type, and kinetics of antibodies (Ab) generated in the oral cavity in response to COVID-19 …
type, and kinetics of antibodies (Ab) generated in the oral cavity in response to COVID-19 …
[HTML][HTML] A simple protein-based surrogate neutralization assay for SARS-CoV-2
…, P Budylowski, AP Dupuis, RC Girardin, B Rathod… - JCI insight, 2020 - ncbi.nlm.nih.gov
Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mount a humoral immune response to the virus within a few weeks of infection, but the …
mount a humoral immune response to the virus within a few weeks of infection, but the …
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
…, C Gervais, C Arnold, B Rathod… - Clinical & …, 2022 - Wiley Online Library
Objectives Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has been instrumental in detecting previous exposures and analyzing vaccine‐…
has been instrumental in detecting previous exposures and analyzing vaccine‐…
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
In most human cancers, only a few genes are mutated at high frequencies; most are mutated
at low frequencies. The functional consequences of these recurrent but infrequent “long tail” …
at low frequencies. The functional consequences of these recurrent but infrequent “long tail” …
[HTML][HTML] Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
…, M Girard, I Lau, R Law, MW Cheung, B Rathod… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Limited information is available on the impact of immunosuppressants on
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID). …
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID). …
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
…, R Samson, BD Griffin, G Babuadze, B Rathod… - Science …, 2022 - science.org
Safe and effective vaccines are needed to end the COVID-19 pandemic. Here, we report the
preclinical development of a lipid nanoparticle–formulated SARS-CoV-2 mRNA vaccine, …
preclinical development of a lipid nanoparticle–formulated SARS-CoV-2 mRNA vaccine, …
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
…, R Samson, K Manguiat, A Robinson, B Rathod… - medRxiv, 2021 - medrxiv.org
Prioritizing Ontario’s long-term care home (LTCH) residents for vaccination against severe
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …